Transitions in relabeling personalized medicine as precision medicine, precision health, or wellness genomics reflect shifting the locus of responsibility for health from individuals to clinicians and in shifting focus from genetic risk to genetic enhancement.
AMA J Ethics. 2018;20(9):E881-890. doi:
Gail Geller, ScD, MHS and Paul A. Watkins, MD, PhD
Six cohorts of first-year medical students have been shown to have negative attitudes about obesity that are consistent over time. Attitudes can be improved, however, by using popular media and an ethics framework to discuss personal experiences and beliefs about obesity.
AMA J Ethics. 2018;20(10):E948-959. doi:
Produce prescription programs can expand patient's food choices and provide financial incentives to change consumption behaviors. If these programs are not linked to established government assistance programs, however, growers could be at risks for bearing the cost.
AMA J Ethics. 2018;20(10):E960-973. doi:
Today’s international health interventions—like colonial treatment campaigns—can be well-intentioned and still oppress and harm people they try to serve. Grasp of imperial medical history is critical for helping global health professionals understand the contexts in which they practice.
AMA J Ethics. 2016;18(7):743-753. doi:
Since the 1960s, drug names have been products of complex, multiparty negotiations in which interests of patients, pharmaceutical firms, clinicians, and US and international regulators must be balanced.
AMA J Ethics. 2019;21(8):E686-696. doi: